Jul 31, 2017 11:30 am UTC| Business
Two patients of four (50%) achieved a complete remissionNo dose-limiting toxicities observed SOUTH SAN FRANCISCO, Calif., July 31, 2017 -- Mateon Therapeutics, Inc. (OTCQX:MATN), a biopharmaceutical company developing...
Kura Oncology to Report Second Quarter 2017 Financial Results
Jul 31, 2017 11:30 am UTC| Business
LA JOLLA, Calif., July 31, 2017 -- Kura Oncology, Inc. (NASDAQ:KURA), a clinical stage biopharmaceutical company focused on the development of precision medicines for oncology, today announced that it will report second...
Rex Energy Announces Date of Second Quarter 2017 Earnings Release
Jul 31, 2017 11:30 am UTC| Business
STATE COLLEGE, Pa., July 31, 2017 -- Rex Energy Corporation (Nasdaq:REXX) today announced plans to release second quarter 2017 financial and operational results on Tuesday, August 8, 2017 after market close. Management...
Jul 31, 2017 11:30 am UTC| Business
WASHINGTON, July 31, 2017 -- FTI Consulting, Inc. (NYSE:FCN) today announced that experts from the Company and its Compass Lexecon subsidiary were recognized in the second edition of the Who’s Who Legal: Consulting...
Macatawa Bank Corporation Increases Quarterly Dividend
Jul 31, 2017 11:30 am UTC| Business
HOLLAND, Mich., July 31, 2017 -- Macatawa Bank Corporation (Nasdaq:MCBC) (the "Company" or "Macatawa") today announced that its Board of Directors has declared a quarterly cash dividend of $0.05 per share on its common...
Jul 31, 2017 11:07 am UTC| Business
OCA met the primary endpoint of alkaline phosphatase (ALP) reduction at 24 weeksAESOP represents a successful proof of concept for OCA in a second cholestatic liver disease Conference call scheduled for 8:30 a.m. ET...
Jul 31, 2017 11:06 am UTC| Business
Low dose atorvastatin rapidly reversed OCA associated LDL changes Conference call scheduled for 8:30 am ET NEW YORK, July 31, 2017 -- Intercept Pharmaceuticals, Inc. (Nasdaq:ICPT) (Intercept), a biopharmaceutical...